Institut National d'Oncologie
Rabat, 10100, Morocco
NCT Number: NCT04349384
The aim of this project is to audit the surgical care in patients treated for colorectal adenocarcinoma. This study focused on collecting data from all consecutive cases of colon and rectal adenocarcinoma operated at the National Institute of Oncology in Rabat during a two-years period. Using standardized forms, the investigators collected data relating to each stage of treatment: pre-therapeutic, surgical and post-operative in order to measure the quality of the surgical care delivered. These results were compared to established benchmarks and to similar audit studies carried out in other countries around the world.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rabat, 10100, Morocco
Quality improvement initiatives and in particular the accreditation procedure raises the inevitable question of measuring quality in health. Several surgical audits have been carried out internationally, showing the importance of collecting reliable and valid information on the quality of care. This approach allows an evaluation and improvement of the quality of care provided, significantly correlated to a direct impact on morbidity and mortality. In addition, it provides valuable information for evidence-based medicine research as it provides data on patients often excluded from therapeutic trials.
Colorectal cancer is the first digestive cancer and the third cancer worldwide. Surgical resection is the main curative treatment. Surgical quality is associated with better short and long term results. Quality improvement measures, with the goal to improve surgical care of colorectal cancer, are becoming a standard worldwide.
The aim of this project is to audit the surgical care in patients treated for colorectal adenocarcinoma. This study focused on collecting data from all consecutive cases of colon and rectal adenocarcinoma operated at the National Institute of Oncology in Rabat. Using standardized forms, the investigators collected data relating to each stage of treatment: pre-therapeutic, surgical and post-operative in order to measure the quality of the surgical care delivered. These results were compared to established benchmarks and to similar audit studies carried out in other countries around the world.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Colon or rectal resection for colorectal adenocarcinoma
Time frame: 1 month after surgery
Number patients with retrieved lymph nodes after colon resection above 12
Time frame: 1 month after surgery
The rate of patients with circumferential margin < 1 mm on surgical specimen of rectal resection for rectal adenocarcinoma.
Time frame: 90 days after surgery
Morbidity assessed using using the Clavien-Dindo grading system at discharge and at 90 days after surgical resection for colorectal adenocarcinoma
Time frame: 7 days after surgery
Rate of patients who had computed tomography before surgery
Time frame: 7 days after surgery
Rate of cases who were discussed during a multidisciplinary team meeting before surgery for patients who had surgical resection for colorectal adenocarcinoma
Time frame: 7 days after surgery
Rate pf patients who had a pelvic Magnetic resonance imaging or rectal ultra-sonography in the pre-operative work-up of rectal adenocarcinoma
Time frame: 90 days after surgery
Rate of anastomotic leakage after resection of colorectal cancer with the creation of anastomosis
Time frame: 90 days after surgery
Rate of hospital readmissions leakage after resection of colorectal cancer
Institut National d'Oncologie, Morocco
Other Gov
Audit of the Quality of Surgical Treatment of Colorectal Cancer
Acronym: AuditCR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03365882
Colon Adenocarcinoma, Colonic Diseases
Anchorage, Alaska, United States
View Trial DetailsNCT05746195
Colon Adenocarcinoma, Colonic Diseases
San Francisco, California, United States
View Trial DetailsNCT02368886
Colon Adenocarcinoma, Colonic Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03436563
Colon Adenocarcinoma, Colonic Diseases
Houston, Texas, United States
View Trial Details